Dr. Chen Wang

CAMS

Dr. Chen WANG is the Vice President of the Chinese Academy of Engineering, President of the Chinese Academy of Medical Sciences and Peking Union Medical College, Director of the National Center for Respiratory Medicine, Vice Chair of the Global Alliance Against Chronic Respiratory Diseases，Board Member of the Global Alliance for Chronic Diseases, and commissioner of The Lancet COVID-19 Commission, He is also an academician of the Chinese Academy of Engineering, an international member of the National Academy of Medicine, a foreign member of Academia Europaea, an ordinary member of the European Academy of Sciences and Arts, and a member of the CAMS Academic Advisory Committee. 

Dr. Wang has over 30 years of experience and specialties in pulmonary and critical care medicine. His primary areas of research include clinical and basic research for complex conditions in respiratory medicine, public health, and health policy. His research and policy interests also include medical education, health system reform and medical technology innovation system. Dr. Wang has published more than 250 articles in international medical journals, including New England Journal of Medicine and The Lancet.

Dr. Richard Horton

Editor-in-Chief of The Lancet

He qualified in physiology and medicine with honours from the University of Birmingham in 1986. He joined The Lancet in 1990, moving to New York as North American Editor in 1993. In 2016, he chaired the Expert Group for the High-Level Commission on Health Employment and Economic Growth, convened by Presidents Hollande of France and Zuma of South Africa. From 2011 to 2015, he was co-chair of the UN's independent Expert Review Group on Information and Accountability for Women's and Children's Health. In 2011, he was elected a Foreign Associate of the US Institute of Medicine and, in 2015, he received the Friendship Award from the Government of China. In 2019 he was awarded the WHO Director-General’s Health Leaders Award for outstanding leadership in global health and the Roux Prize in recognition of innovation in the application of global health evidence.  He now works to develop the idea of planetary health – the health of human civilizations and the ecosystems on which they depend. In 2020, he published The COVID-19 Catastrophe: What’s Gone Wrong and How to Stop It Happening Again. A revised, updated, and expanded second edition was published in 2021.

Prof. Weizhong Yang

CAMS

Prof. Yang Weizhong, Executive Head, School of Population Medicine & Public Health, Chinese Academy of Medical Sciences/Peking Union Medical College Vice President and Secretary General of Chinese Preventive Medicine Association, Former Deputy General Director of Chinese Center for Disease Control and Prevention.

Since 1982, he has been engaged in infectious disease surveillance, prevention and control, immunization planning management, and public health management in Sichuan Provincial Epidemic Prevention Station, Chinese Center for Disease Control and Prevention, and Chinese Preventive Medicine Association. In recent 10 years, as the first author or corresponding author, he has published more than 50 papers in international and journals such as The New England Journal of Medicine, Lancet, Vaccine, Public Health, PLoS ONE, Emerging Infectious Disease, BMJ, PLoS Medicine, Health Affairs, BMC Infectious Diseases etc. He edited the Early Warning for Infectious Disease Outbreak: Theory and Practice published by Elsevier. He was the editor-in-chief of The Lancet Infectious Diseases Volume (Chinese Version), and the deputy editor of the Vaccine. (Chinese Version).

Dr. Helena Wang

Dr. Jianwei WANG

CAMS

Dr. Jianwei WANG is Vice President of Chinese Academy of Medical Sciences (CAMS), Vice Chancellor of Peking Union Medical College (PUMC). He has over 25 years of experience and specialties in pathogenic mechanism, prevention and control of respiratory viral infectious diseases. He has taken the leading role in nearly 20 National Scientific and Technology Research & Development Projects. He also serves as a member of the project of "prevention and control of major infectious diseases such as AIDS and viral hepatitis", and a Member of the national advisory group of "research and development of key technologies for biosafety". Dr. Wang is the Executive Editor of Biosafety & Health and the member of Editorial Committee of Frontiers in Microbiology. He has published more than 110 peer reviewed articles in international journals, including Lancet, Am J Resp Med Crit Care, Cell Host & Microbe, PNAS, Nat commun, Microbiome. He is one of the highly cited researchers 2020 in China released by Elsevier.

Audrey Ceschia

Editor of The Lancet Public Health

Audrey completed her PhD in Biology and Health in 2005 at the University of Montpellier, France. She joined The Lancet journals in 2008 as a Senior Editor. Since 2016, she is the founding Editor-in-Chief of The Lancet Public Health—an open access monthly journal committed to tackling the most pressing or neglected issues across all aspects of public health. In line with the values and vision of The Lancet, Audrey has a strong commitment to using science as an important means to improve health equity.

Shang Hong

Shang Hong, laboratory medicine and AIDS prevention & treatment scientist, Academician of China Academy of Engineering, Fellow of the Chinese Academy of Medical Sciences. She is currently the director of the First Affiliated Hospital of China Medical University and director of the National Clinical Research Center for Laboratory Medicine. She is also the vice chairman of the Chinese Medical Association, the director of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM), the chairman of the Chinese Medical Doctor Association of Lab Medicine. She has long been engaged in the research of HIV key laboratory areas and clinical laboratory standardization. As the first or corresponding author, she has published more than 300 research papers such as Nature, N Engl J Med, Lancet Infect Dis and Nat Immunol; 12 industry standards were formulated. She won 2 second prizes of National Scientific and Technological Progress Award, HO LEUNG Ho LEE (HLHL) Foundation for Scientific and Technological Progress Award and French National Academy of Medicine-Servier.

Dr. Sabine Kleinert

Senior Executive Editor of The Lancet

Sabine Kleinert is a Senior Executive Editor at The Lancet. She is a member of the Senior Management Team of The Lancet Group with responsibilities for research integrity, publication ethics, and Open Access policies. In 2018, she initiated Preprints with The Lancet in partnership with SSRN as one of the first medical preprint offerings. She served as Vice-Chair of the Committee on Publication Ethics from 2006 to March 2012 and was involved in the Conferences on Research Integrity from their beginning in 2007. She is a member of the Governing Board of the World Conferences on Research Integrity Foundation and Co-Chair of the 7th World Conference on Research Integrity, to be held in Cape Town, South Africa, in 2022. Her background is qualification as a medical doctor in Germany and training as a Paediatrician and Paediatric Cardiologist in the UK, Belgium, Australia, the USA, and Australia.

Youlin Qiao, M.D.; Ph.D.

Professor & Director, Center for Global Health,

School of Population Medicine & Public Health

Chinese Academy of Medical Sciences  Peking Union Medical College

Dr. Qiao has been trained in preventive medicine from Sichuan Medical College and Dalian Medical College, China, Johns Hopkins University Bloomberg School of Public Health as well as National Cancer Institute/National Institutes of Health, USA. As an expert in cancer prevention and control, he is involved in many national and international projects to study etiology, primary intervention including HPV vaccines, and early detection of a variety of cancers through multidisciplinary and global collaborations for helping to promote cancer prevention and control programs in developing countries.

He is an author on over 526 peer reviewed publications in both English and Chinese with 26,500+ citations and h-index 80. He has been the Most Cited Chinese Researchers For exceptional research performance in the field of Medicine for seven consecutive years from 2014 to 2020 (by Elsevier) and the top 15 academy impact in public health-preventive medicine of China in 2021.

Dr. Tamara Lucas

Executive Editor of The Lancet

Tamara studied Anthropology at University College London, followed by a Master’s Degree at London’s Royal College of Art. After several years spent working as a curator of ethnography and Indigenous art in the UK and Australia, Tamara moved into publishing, joining Elsevier in 2007, followed by The Lancet in 2013. Tamara is particularly interested in climate change, and food systems and nutrition.

Ruitai SHAO, MD., MSc, PhD

Cross cutting lead for policy, research and innovation

Department of noncommunicable disease

World Health Organization, Geneva

Prof Ruitai Shao joined the World Health Organization (WHO) in Sept 2001 as a high-level expert and has been providing technical guidance and advice on NCD prevention and control with focus on national NCD plans, polices and NCD research & innovation   for countries. He has also been working with the selected countries to identify GAPs, barriers and challenges in prevention and control of noncommunicable diseases，and develop implementation strategies to address these issues in order to achieve better impact of implementing the cost-effective interventions and NCD targets and SDG3.4. Prior to this, he coordinated the WHO global forum on NCD prevention and control and managed the integrated NCD prevention and control program. 

Prof Ruitai Shao was a senior public health specialist, vice president of Chinese Academy of Preventive Medicine (CAPM) and also was Deputy Director-General of department for the prevention and control of both communicable and noncommunicable diseases (NCDs) and public health strategies, policies and plans in Ministry of Health. 

Prof Ruitai Shao holds a medical degree in medical science and a master’s degree in social medicine & health management from Peking University, and a PhD in public health management from Fudan University in Shanghai. 

Dr. Marta Koch

Editor-in-Chief of The Lancet Diabetes & Endocrinology 

Marta Koch began her research career at the Porto Oncology Institute, Portugal, in 2000. She was awarded a doctorate degree in biomedical sciences from The University of Leuven, Belgium, and has pursued postdoctoral studies at the University of Leuven and at The Scripps Research Institute, Florida, USA. Marta has been a professional editor since joining the journal Cell in 2015. Her editorial experience extended through diverse basic science, translational and clinical research topics. She joined the Lancet group in 2018 as the inaugural Editor-in-Chief of EClinicalMedicine. She has been serving the diabetes and endocrinology communities as Editor-in-Chief of The Lancet Diabetes & Endocrinology since early 2019.

Xiaoying Zheng

Dr. Zheng is a Special Professor of the Changjiang Scholar Incentive Program and Winner of the National Science Fund for Outstanding Young Scholars, and engaged in population health and epidemiology research for a long time. She is currently a Boya Distinguished Professor of Peking University, professor of Institute for Global Health and Development, Dean of APEC Health Science Academy, and professor Institute of population research. She is currently serving as the Chinese Representative for the Washington Group on Disability of UN, Member of the APEC Life Sciences Innovation Forum Executive Board, Vice Director of the China Association of Rehabilitation of Disabled Persons, Vice President of the China Association of China Association of Gerontology and Geriatrics, Chief Member of the Professional Committee on Disability Prevention and Control of the Chinese Preventive Medicine Association. She was appointed as an expert of the drafting committee for the Regulations on Disability Prevention and Recovery of the Disabled issued by the State Council of China and the Group Leader of the Expert Technical Group of the National Action Plan on Disability Prevention. In 2016, she was elected as the Fellow of The World Academy of Sciences (UN-TWAS).

Esther Lau

Deputy Editor of The Lancet Child & Adolescent Health

Esther Lau is Deputy Editor of The Lancet Child & Adolescent Health, having joined the journal’s launch team in 2017 as Senior Editor. She handles fast-track peer review and was the lead editor of The Lancet Child & Adolescent Health Commission on Delivering transformative action in paediatric pain. She is passionate about youth engagement in research and recently helped the journal launch its inaugural Youth Advisory Panel. She is also part of the Group for Racial Equality, the Gender & Diversity Taskforce, and the selection panel of The Wakley–Wu Lien Teh Prize at The Lancet Group. She studied natural sciences (biochemistry) at the University of Cambridge (UK).